Cargando…
Histone Deacetylase Inhibitors Increase p27(Kip1) by Affecting Its Ubiquitin-Dependent Degradation through Skp2 Downregulation
Histone deacetylase inhibitors (HDACIs) represent an intriguing class of pharmacologically active compounds. Currently, some HDACIs are FDA approved for cancer therapy and many others are in clinical trials, showing important clinical activities at well tolerated doses. HDACIs also interfere with th...
Autores principales: | Borriello, Adriana, Naviglio, Silvio, Bencivenga, Debora, Caldarelli, Ilaria, Tramontano, Annunziata, Speranza, Maria Carmela, Stampone, Emanuela, Sapio, Luigi, Negri, Aide, Oliva, Adriana, Sinisi, Antonio Agostino, Spina, Annamaria, Della Ragione, Fulvio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670678/ https://www.ncbi.nlm.nih.gov/pubmed/26682002 http://dx.doi.org/10.1155/2016/2481865 |
Ejemplares similares
-
p27(Kip1), an Intrinsically Unstructured Protein with Scaffold Properties
por: Bencivenga, Debora, et al.
Publicado: (2021) -
High Dosage Lithium Treatment Induces DNA Damage and p57(Kip2) Decrease
por: Stampone, Emanuela, et al.
Publicado: (2020) -
Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions
por: Borriello, Adriana, et al.
Publicado: (2016) -
A cancer‐associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss‐of‐function
por: Bencivenga, Debora, et al.
Publicado: (2021) -
A Beckwith–Wiedemann-Associated CDKN1C Mutation Allows the Identification of a Novel Nuclear Localization Signal in Human p57(Kip2)
por: Stampone, Emanuela, et al.
Publicado: (2021)